Clinical trial
Vaccine Therapy in Treating Patients With Liver or Lung Metastases From…
NCT00103142 · Michael Morse, MD, Other · Completed
Key facts
| NCT number | NCT00103142 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer |
| Official title | A Phase II Study of Active Immunotherapy With PANVAC or Autologous, Cultured Dendritic Cells Infected With PANVAC After Complete Resection of Hepatic or Pulmonary Metastases of Colorectal Carcinoma |
| Lead sponsor | Michael Morse, MD, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | falimarev, inalimarev, sargramostim, therapeutic autologous dendritic cells |
| Enrollment | 74 |
| Start date | Feb 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Mar 1, 2013 |
| First posted | Feb 8, 2005 |
| Last update posted | Oct 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: